France - A New Method, New Framework, and New Roadmap for Improved Patient Access Webinar
20.12.19 - 20.12.19
About the webinar
In France, it takes 530 days between market authorisation and patients having access to a new medicine. It’s 374 days in Spain, 111 in the UK, and 106 in Germany. In this webinar we discuss the current challenges to access new, innovative oncology treatments in Europe, as well as reforming processes to make reimbursement pathways clearer and more efficient. The objective is to foster timely and appropriate access for those patients with unmet medical needs, and increased clarity and certainty around regulatory access decisions.
This webinar is the first in a series of two webinars in the run-up to the European Cancer Forum on January 28, 2020, in Brussels. For more information and to register for this conference please visit www.europeancancerforum.eu.
Speakers
In France, it takes 530 days between market authorisation and patients having access to a new medicine. It’s 374 days in Spain, 111 in the UK, and 106 in Germany. In this webinar we discuss the current challenges to access new, innovative oncology treatments in Europe, as well as reforming processes to make reimbursement pathways clearer and more efficient. The objective is to foster timely and appropriate access for those patients with unmet medical needs, and increased clarity and certainty around regulatory access decisions.
This webinar is the first in a series of two webinars in the run-up to the European Cancer Forum on January 28, 2020, in Brussels. For more information and to register for this conference please visit www.europeancancerforum.eu.
Speakers